A second Trump presidency could reshape global abortion rights and women’s healthcare, influencing reproductive policies ...

International: The US is by far the largest donor of aid for global health, providing US$15.8 billion (£7.8 billion) in 2022, ...

Owkin, the first end-to-end AI-biotech that uses cutting-edge causal AI to unlock precision drug discovery, development, and diagnostics, and Proscia ®, a global leader in AI-enabled pathology ...

The third quarter wafer shipment results continued the upward trend which started in the second quarter of this year,” said ...

MSI, a leading global provider of high-performance server solutions, unveiled its AI server based on the NVIDIA MGX™ ...

Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer: Princeton, New Jersey Monday, November 18, 2 ...

Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a combination therapy consisting of ...

Donald Trump's re-election as US president has led to widespread concern about the future of abortion rights and not just in ...

Patients with MSI-high/dMMR advanced colorectal cancers had a 79 percent lower risk of disease progression or death on Opdivo-Yervoy compared to chemo.

Leading international reproductive health charity MSI Reproductive Choices saw its overall funding fall by 17% in 2017 during ...

MDNA11 continues to show best-in-class potential in the ABILITY-1 study with an objective response rate (ORR) of 30% in the monotherapy dose expansion cohort among patients with cancer progression aft ...